SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Caladrius Biosciences Q1 EPS $(0.380) Misses $(0.290) Estimate

Caladrius Biosciences (NASDAQ:CLBS) reported quarterly losses of $(0.380) per share which missed the analyst consensus estimate of $(0.290) by 31.03 percent. This is a 13.64 percent increase over losses of $(0.440) per

Benzinga · 05/07/2020 20:46

Caladrius Biosciences (NASDAQ:CLBS) reported quarterly losses of $(0.380) per share which missed the analyst consensus estimate of $(0.290) by 31.03 percent. This is a 13.64 percent increase over losses of $(0.440) per share from the same period last year.